IndiGo to lease Boeing 787-9 from Norse Atlantic for long-haul expansion

Budget-carrier IndiGo has signed a lease agreement with Norway-based Norse Atlantic Airways for a Boeing 787-9 Dreamliner, the Norwegian airlines said in a press release on Thursday. The aircraft is expected to begin operations in March 2025, marking a key step in IndiGo’s efforts to expand its long-haul international services.  

“This contract represents an important milestone for Norse as we partner with one of the largest and most reputable airlines in the world. We look forward to support IndiGo’s long haul services, and to deliver an exceptional travel experience to their customers” said Bjorn Tore Larsen, CEO and founder of Norse Atlantic Airways.

Under the agreement, Norse Atlantic will provide the aircraft, pilots, and maintenance services, while IndiGo will deploy its own cabin crew. The initial lease term is for six months, with the possibility of an extension up to 18 months, subject to regulatory approvals. Both airlines are also exploring further collaboration, potentially involving additional aircraft. 

Norse Atlantic Airways has said it signed a wet lease agreement with IndiGo. However, a report by Reuters claimed that the agreement was for a damp lease. 

Damp vs wet lease agreements

A wet lease is an arrangement in which one airline (the lessor) provides an aircraft along with its crew, maintenance, and insurance to another airline (the lessee).

A damp lease falls between a wet lease and a dry lease. In a damp lease, the lessor supplies the aircraft, maintenance, insurance, and some crew members, while the lessee provides the remaining crew. In contrast, a dry lease only includes the aircraft, with no crew or additional services provided. 

IndiGo’s fleet and international expansion

Currently, IndiGo flies to 38 international destinations and plans to add two more by March 2025.

At the end of 2024, IndiGo had 14 jets on damp lease—two from Turkish Airlines and 12 from Qatar Airways. The airline is expected to lease up to six Boeing 787s from Norse Atlantic, according to earlier reports. IndiGo will also take delivery of its first Airbus A321XLR in 2025, a single-aisle aircraft capable of non-stop flights from India to Western Europe.

IndiGo aims to capture a larger share of India’s international travel market, currently dominated by Gulf carriers offering one-stop flights. The airline deploys about 28 per cent of its capacity on international routes, serving destinations from Baku to Bali. 

To support its long-haul ambitions, IndiGo has placed a firm order for 30 Airbus A350-900s, with an option for 70 more, expected for delivery from 2027.

Eqwires Research Analyst

Top-notch SEBI registered research analyst

Best SEBI registered Intraday tips provider

info@eqwires.com

Telegram Facebook Instagram

Call: +91 9624421555 / +91 9624461555

www.eqwires.com

Swiggy Q3 results: Net loss widens 39% to Rs 799 crore

Food delivery platform Swiggy Ltd on February 5 reported that its net loss widened 39 percent to Rs 799 crore in the quarter ended December 31, 2024, regulatory filings showed. It reported a net loss of Rs 574 crore in the year-ago period.

Swiggy’s revenue from operations rose 31 percent to Rs 3,993 crore in Q3FY25 as against Rs 3,049 crore in Q3FY24.

“The secular expansion in Food delivery margins and cash flow generation is balanced by growth investments being made in Quick-commerce including dark stores expansion and marketing, amidst high competitive intensity in the near-term,” Sriharsha Majety, MD and Group CEO, Swiggy said in a prepared statement.

Swiggy’s results have come at a time when old rival Zomato also saw its profits decline 57 percent on a year-on-year (YoY) basis to Rs 59 crore in the Q3.

While the Gurugram-based company saw its revenue from operations rise 64 percent YoY to Rs 5,404 crore in Q3, up from Rs 3,288 crore a year ago. While it had reported a 64 percent YoY increase in revenue to Rs 5,404 crore in the previous quarter, Zomato had flagged concerns of a slowdown in the food delivery space.

Bengaluru-based Swiggy saw its gross order value (GOV) grow 38 percent YoY to Rs 12,165 crore, while its consolidated adjusted EBITDA loss reduced around 2 percent YoY to Rs 490 crore. However on a sequential basis, EBITDA loss was up slightly to Rs 149 crore, filings showed.

On February 5, Swiggy’s shares on BSE closed trading 3.6% lower at Rs 418.6 apiece.

Eqwires Research Analyst

Top-notch SEBI registered research analyst

Best SEBI registered Intraday tips provider

info@eqwires.com

Telegram Facebook Instagram

Call: +91 9624421555 / +91 9624461555

www.eqwires.com

Q3 Results: Whirlpool India, Titan, Happiest Minds, Asian Paints, and PC Jewellers among 130 firms to announce earnings today; check list

As many as 130 companies are slated to declare their December quarter (Q3 FY25) earnings on Tuesday, February 4. The list includes names such as Asian Paints, Titan Company, Bajaj Electricals, BASF India, Godrej Properties, Whirlpool of India, Happiest Minds Technologies, Hikal, and Infibeam Avenues.

Other names that will release their results are JK Tyre & Industries, Lemon Tree Hotels, Max Financial Services, Medanta, One Mobikwik Systems, Safari Industries, Zydus Wellness, and V-Mart, among others.

Check the list.

  • Apollo Micro Systems
  • Asian Paints
  • Titan Company
  • Bajaj Electricals
  • BASF India
  • Godrej Properties
  • Whirlpool of India
  • Happiest Minds Technologies
  • Hikal,
  • Infibeam Avenues
  • JK Tyre & Industries
  • Lemon Tree Hotels
  • Max Financial Services
  • Medanta
  • One Mobikwik Systems
  • Safari Industries
  • Zydus Wellness,
  • V-Mart

On Monday, Power Grid Corporation of India (Powergrid) reported a 4% decline in its consolidated net profit to ₹3,861.63 crore for the December 2024 quarter.

It had posted ₹4,028.25 crore net profit in the year-ago quarter, the company said in an exchange filing.

The company’s total income reduced to ₹11,743.06 crore from ₹11,819.70 crore in the October-December quarter of the preceding fiscal.

Meanwhile, drug firm Divi’s Laboratories on Monday said its profit after tax (PAT) increased 65% to ₹589 crore for the December quarter, on the back of robust sales across markets.

The company reported a profit after tax (PAT) of ₹358 crore for the October-December quarter of the last fiscal.

Revenue from operations rose to ₹2,319 crore in the third quarter as against ₹1,855 crore in the year-ago period, Divi’s Laboratories said in a regulatory filing.

Castrol India Ltd on Monday reported a 12% increase in profit after tax (PAT) at ₹271 crore in the December quarter. The company had posted a PAT of ₹242 crore in the October-December period of 2023, Castrol India said.

Castrol India follows the January-December period as its financial year.

Revenue from operations rose 7% to ₹1,354 crore for the reporting quarter, it said.

Eqwires Research Analyst

Top-notch SEBI registered research analyst

Best SEBI registered Intraday tips provider

info@eqwires.com

Telegram Facebook Instagram

Call: +91 9624421555 / +91 9624461555

www.eqwires.com

Rail Vikas Nigam share price rises up to 4% on ₹404 crore order update

Rail Vikas Nigam Ltd (RVNL)share price gained up to 4% in the intraday trades on Wednesday on ₹404 crore order update.

Rail Vikas Nigam Ltd (RVNL)share price opened at ₹410.05 on the BSE on Wednesday, more than 2% higher than the previous closing price of ₹400.20. The RVVNL share price thereafter gained further to highs of ₹416.30 which meant gains of more than 4%

The Rail Vikas Nigam Ltd share price has corrected significantly from 52 week highs of ₹647 in July. However order book remains strong and is growing

Rail Vikas Nigam Ltd (RVNL) order details

Rail Vikas Nigam Ltd in its intimation to exchanges on 4 February 2025 informed about receiving Letter of Acceptance received from East Coast Railway.

Rail Vikas Nigam Limited in its intimation said that it has received Letter of Acceptance from East Coast Railway for “Koraput-Singapur Road Doubling Project: Execution of 27 Nos of Major Bridges i.e. (22 Nos of Major Bridges & 5 Nos of ROBs) and earth work in formation of approaches, protection works and other connected miscellaneous works between Tikiri and Bhalumaska stations in connection with Koraput-Singapur Road Doubling Project of Waltair Division, East Coast Railway.

The time period for the completion by Rail Vikas Nigam Ltd is 30 Months

The broad consideration or the project cost is ₹404,40,32,985.00/- (Rupees Four Hundred Four Crore Forty Lakh Thirty Two Thousand Nine Hundred Eighty Five Only) (Including GST)

While the order boosted the investors sentiments, leading to 4% gains for the stock, nevertheless the stock gave up part of the gains. The investors will be watchful of RVNL Q3 performance to be declared soon.

RVNL also in another intimation to the exchanges on 4 January said that the meeting of the Board of Directors of Rail Vikas Nigam Ltd is scheduled on 12/02/2025 ,inter alia, to consider and approve the Unaudited Financial Results (Standalone and Consolidated) of the Company for the Quarter and nine months ended 31st December, 2024

Eqwires Research Analyst

Top-notch SEBI registered research analyst

Best SEBI registered Intraday tips provider

info@eqwires.com

Telegram Facebook Instagram

Call: +91 9624421555 / +91 9624461555

www.eqwires.com

Gland Pharma shares slip 5% on disappointing revenue growth in Q3

Shares of Gland Pharma slipped 5 per cent to Rs 1,437.70 on the BSE in Tuesday’s intra-day trade after the company’s revenues de-grew 10 per cent year-on-year (YoY) to Rs 1,384 crore in the December quarter (Q3FY25). The company’s topline was impacted by the low base business arising due to a dip in volumes in the US as well as some shipment delays to Saudi Arabia. 

In comparison, the BSE Sensex was up 0.3 per cent at 77,417, at 10:40 AM. The stock price of Gland Pharma had hit a 52-week low of Rs 1,413.75 on January 28, 2025. It has corrected 35 per cent from its 52-week high level of Rs 2,220.95 touched on August 6, 2024.

The company’ reported earnings before interest, tax, depreciation and amortisation (Ebitda), on the other hand, grew 1 per cent YoY to Rs 360 crore, and margins stood at 26 per cent (300 bps growth) driven by a strong 535 bps improvement in gross profit margin. Profit after tax grew 7 per cent YoY to Rs 204.7 crore. 

In the base business, the US de-grew 12 per cent YoY to Rs 713.5 crore due to a postponement of supplies of blood thinner, Enoxaparin to the next quarter. Rest of world (RoW) reported 6 per cent YoY growth to Rs 167 crore, while the domestic business de-grew 26 per cent YoY to Rs 56 crore. The Cenexi business remained impacted due to machinery breakdown in a Belgium plant and to address observations emanating from an unannounced inspection by the French regulator.

On a negative note, the company’s management now expects the Cenexi turnaround to happen in Q3FY26F (vs. Q4FY25F earlier), given the Lyophilizer breakdown at the Belgium plant and the observations received for the Fontenay, Belgium, plant from the French health authorities at the recent inspection.

ICICI Securities said Gland’s base business revenues were negatively impacted by the postponement of Enoxaparin revenues to the next quarter but this had positive implications on the margins as Enoxaparin fetches lower margins. The Cenexi business was also impacted by unforeseen events, however the postponement of positive margins (Ebitda) to Q3FY26 is a matter of slight concern. 

That said, the brokerage firm expects normalcy to return in a quarter or two. The future holds good for Gland with the expected approvals for complex products , GLP 1 contract signing and an agreement with a Chinese biotech player for biosimilars besides incremental Cenexi revenues from the new high-speed line from Fontenay plant. The new CEO has been assigned to take charge of RoW and India businesses, ICICI Securities said in a note. 

Analysts at InCred Equities said they are disappointed with the repeated delay in Cenexi’s turnaround and will reassess the situation constructively once the facility is back on track. It has been nearly seven quarters since Cenexi’s acquisition, and it will take another three-to-four quarters for the business to normalise, they said. 

While Gland’s core business continues to outperform, Cenexi’s ongoing challenges will remain a drag in the near-term. As a result, the brokerage firm has reduced its FY25F/26F EPS estimates by 14 per cent/24 per cent, respectively, and lowered the target price to Rs 1,313, from Rs 1,768 earlier. A faster-than-expected ramp-up at Cenexi remains a key upside risk, the brokerage firm said in the company’s results update.

Eqwires Research Analyst

Top-notch SEBI registered research analyst

Best SEBI registered Intraday tips provider

info@eqwires.com

Telegram Facebook Instagram

Call: +91 9624421555 / +91 9624461555

www.eqwires.com